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A B S T R A C T
Chorein is a protein of the Vps13 family, and defects in this protein cause the rare neurodegenerative disorder
chorea-acanthocytosis (ChAc). Chorein is involved in the actin cytoskeleton organization, calcium ion flux,
neuronal cell excitability, exocytosis and autophagy. The function of this protein is poorly understood, and
obtaining this knowledge is a key to finding a cure for ChAc. Chorein, as well as the Vps13 protein from yeast,
contains the APT1 domain. Our previous research has shown that the APT1 domain from yeast Vps13 (yAPT1v)
binds phosphatidylinositol 3-phosphate (PI3P) in vitro. In this study, we showed that although the APT1 domain
from chorein (hAPT1) binds to PI3P it could not functionally replace yAPT1v. The hAPT1 domain binds, in
addition to PI3P, to phosphatidylinositol 5-phosphate (PI5P). The binding of hAPT1 to PI3P, unlike the binding
of yAPT1v to PI3P, is regulated by the bivalent ions, calcium and magnesium. Regulation of PI3P binding via
calcium is also observed for the APT1 domain of yeast autophagy protein Atg2. The substitution I2771R, found
in chorein of patient suffering from ChAc, reduces the binding of the hAPT1 domain to PI3P and PI5P. These
results suggest that the ability of APT1 domains to bind phosphoinositides is regulated differently in yeast and
human protein and that this regulation is important for chorein function.
1. Introduction
Vps13 proteins are preserved in all eukaryotic organisms. There is
one member of the Vps13 protein family in yeast and four in humans.
Human Vps13 proteins, encoded by the hVPS13A (9q21.2), B (8q22.2),
C (15q22.2) and D (1p36.22) genes, are associated with several neu-
rological disorders. The hVPS13A gene encodes chorein, defects in
which cause chorea-acanthocytosis (ChAc) [1–4], an ultra-rare her-
editary neurological disorder that manifests in patients as difficulties in
movement, presence of acanthocytes (spiked red blood cells) and pro-
gressive neurodegeneration [5,6]. Little is known regarding the mole-
cular mechanism of ChAc pathogenesis. Various studies have shown
several changes in cell physiology, such as alterations in actin cytos-
keleton network formation [7,8] calcium (Ca2+) ion flux [9], neuronal
cell excitability [10], exocytosis [11] and autophagy [12]. Some of
these defects appear to be due to changes in cellular signalling via the
tyrosine kinase Lyn and phosphoinositide 3-kinase (PI3K) [13,14].
More is known about the Vps13 protein from yeast (hereafter referred
to as Vps13), which shares approximately 40% similarity with chorein
[2]. Thus, the studies conducted on the Vps13 protein could be con-
sidered as a source of information regarding the possible functions of
chorein.
Different Vps13 proteins have been shown to localize to various
membrane contact sites (MCSs), where membranes of two different
organelles are in close proximity [15,16]. The MCS structure is regu-
lated in response to growth conditions and changes in cell metabolism
[17], and MCSs are involved in lipid and ion transport, lipid bio-
synthesis, and communication between organelles. On glucose-con-
taining media, Vps13 was detected in vacuole and mitochondria pat-
ches (vCLAMPs) [18] or endosome-mitochondria MCSs [19], but on
glycerol-containing media, Vps13 was detected in nuclear vacuole
junctions (NVJs) [20]. In addition, amino acid substitutions in Vps13
allow this protein to compensate for the lack of the Mmm1 protein, a
subunit of the endoplasmic reticulum (ER)-mitochondria encounter
structure (ERMES), which is the protein complex implicated in ER-mi-
tochondria MCSs formation [18]. Recent data have also shown the
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presence of chorein in ER-mitochondria or ER-lipid droplet MCSs and
hVps13C in ER-endosome or ER-lipid droplet MCSs [21,22]. Moreover,
the ability of the N-terminal part of Vps13 to transfer glycerolipids
between liposomes was demonstrated in an in vitro assay [21]. The
pivotal function of Vps13 proteins is perhaps lipid transfer in MCSs.
However, the mechanism by which Vps13 localizes to different MCSs
remains to be determined.
The Vps13 of Saccharomyces cerevisiae is a large 358-kDa protein
with several domains, including the Vps13 Adaptor Binding (VAB)
domain (WD-40 like) [23], the APT1 [24] and PH-like domains in the C-
terminal part [23,25]. This domain structure is conserved and the WD-
40 like, APT1 and PH-like domains are also present in chorein [21,25].
All of the listed domains could participate in establishing different
MCSs. This could be achieved by interaction with phosphoinositides
(PIPs), a class of short-lived membrane phospholipids that mediate
crucial cellular functions via recruitment of proteins containing specific
domains. Indeed, many of the domains/regions of Vps13 were docu-
mented to be able to bind lipids in vitro. The N-terminal part (amino
acids residues (aa) 1–437) interacts with phosphatidic acid (PA) and
phosphoinositides (PIPs), such as phosphatidylinositol 4-phosphate
(PI4P) and phosphatidylinositol 4,5-bisphosphate PI(4,5)P2, while the
C-terminal part (aa 2905–3144) binds to PI(4,5)P2. The central region
(aa 2158–2575) binds all PIPs, PA and lysophosphatidic acid (LPA)
[26]. We described the APT1 (yAPT1v) domain (aa 2492–2844) as in-
teracting almost exclusively with phosphatidylinositol 3-phosphate
(PI3P) [24]. Recent investigations show that targeting of Vps13 to
different membranes is mediated not only by lipid binding, but also by
interaction with several adaptor proteins via PxP motifs present in the
VAB domain [27]. Modulation of the interaction of Vps13 proteins with
different partners (lipids and proteins) is important because this mod-
ulation influences Vps13 localization and thus abolishes or promotes its
function at particular locations.
Ca2+ ions play a significant role in cellular signalling [28]. Several
proteins are molecular sensors that are sensitive to Ca2+ ions. Many of
these proteins are lipid-binding proteins that bind to membranes and
are regulated by the presence of Ca2+. Some examples of these proteins
are synaptotagmin-1, which binds Ca2+ cooperatively with PI(4,5)P2
[29], and protein kinase C, which interacts with the lipid bilayer in the
presence of Ca2+ [30]. Upon binding to Ca2+, proteins are able to
change their conformation and charge, which ultimately affects their
potential interactions and signal transduction. Magnesium (Mg2+) ions
are essential without any known specific regulatory functions. The
concentration of these ions in the cell is relatively high. There are few
reports describing the role of Mg2+ in the regulation of the ability of
proteins to bind phospholipids. Some reports state that the synapto-
tagmin-3 protein acts as a Mg2+-dependent sensor of negatively
charged phospholipids [31,32].
The Atg2 protein, which belongs to the family of autophagy-related
proteins, shares sequence similarity at the N- and C-terminal region to
chorein. We documented that the Atg2 possesses the APT1 domain
(yAPT1a) domain which binds PI3P [33]. Recently, it was shown that
the N-terminal fragment of Atg2, similar to N-terminal part of Vps13,
transfers lipids in vitro [34].
Previously, we reported that the yAPT1a and yAPT1v domains bind
PI3P [24,33]. Here, we studied the lipid binding specificity of the APT1
domain from chorein (hAPT1) in comparison to those of the yeast
Vps13 and Atg2 proteins and the effect of Ca2+ and Mg2+ ions on the
binding of APT1 domains to PIPs. We found that the hAPT1 domain,
similar to yAPT1a and yAPT1v, binds PI3P and that this binding is
regulated by bivalent cations. Moreover, we show that the hAPT1 do-
main is able to bind PI5P and this binding is not regulated by metal
ions.
2. Materials and methods
2.1. Strains, media and growth conditions
The E. coli strain XL1-Blue (Stratagene, San Diego, USA) was used
for plasmid propagation. The E. coli strain SoluBL21 (Genlantis, San
Diego, USA) was used for heterologous expression of proteins. The yeast
S. cerevisiae strains used in this study include BY MET15 (MATa his3Δ1
leu2Δ0 MET15 ura3Δ0) and BY MET15 vps13Δ (MATa his3Δ1 leu2Δ0,
MET15 ura3Δ0 vps13Δ::KanMX) (W. Rzepnikowska, PhD thesis).
E. coli cells were grown in liquid LB medium supplemented with
ampicillin at 37 °C for plasmid propagation or at 28 °C for heterologous
protein expression. Yeast cells were grown at 28 °C in liquid YPD
medium (1% yeast extract, 2% bactopeptone, 2% glucose) or in syn-
thetic complete medium (SM; 0.67% yeast nitrogen base without amino
acids, 2% glucose) with the appropriate supplements (uracil and amino
acids) if plasmid selection was required. For the growth test, the cells
were grown overnight in SC-ura medium, pelleted and resuspended to
OD600 = 1 in water, and 1:4 serial dilutions were prepared. Aliquots of
each dilution were spotted on YPD plates (YPD, 2.5% agar), YPD plates
supplemented with 0.0175% sodium dodecyl sulfate (SDS), SC-ura
minimal plates (SC, 2.5% agar) with required supplements and SC-ura-
arg plates supplemented or not with 2 μg ml−1 L-canavanine and then
incubated at 28 °C for 3–5 days.
2.2. Plasmids and plasmid construction
The plasmids used in this study are listed in Table S1. Plasmids with
chimeric VPS13 genes were constructed by homologous recombination
in E. coli [35]. First, 2388-bp SalI/SalI fragment from pUG35-VPS13
was cloned into pBluescript2SK+, and fragment missing approximately
1100-bp corresponding to yAPT1v was amplified by PCR. Two pro-
ducts, namely, 1124-bp hVPS13A-hAPT1 and 1124-bp hVPS13A-hAPT1-
I2771R, flanked by sequences homologous to appropriate sites in vps13
fragments cloned previously into pBluescript2SK+, were produced.
The 4249-bp or 3826-bp PCR products were mixed with the 1124-bp
hVPS13A-hAPT1 or 1124-bp hVPS13A-hAPT1-I2771R PCR products,
and these mixtures were transformed into E. coli. After isolation, the
proper plasmids were digested with SalI and cloned into pUG35-VPS13
SalI/SalI to yield pDK305 or pDK306.
The pDK304 plasmid was constructed by one-step site-directed
mutagenesis. pBluescript2SK+ plasmids with a 2388-bp SalI/SalI
fragment from digested pUG35-VPS13 were amplified by PCR. The PCR
product lacking an approximately 1100-bp fragment coding for yAPT1v
was self-ligated. After isolation, the plasmid was digested with SalI and
cloned into pUG35-VPS13 SalI/SalI.
For the production of truncated chorein variants in E. coli, appro-
priate constructs encoding N-terminally GST-tagged proteins were
created. The pKF463 vector, encoding the GST tag alone, was used as a
control. This vector is based on the pGEX-4T-1 backbone and carries a
STOP codon directly downstream of the encoded TEV protease cleavage
site [33]. Appropriate hVPS13A fragments were PCR-amplified from
p415-PTEF1-hVPS13A and cloned into pKF463. The hVPS13A-hAPT1 or
hVPS13A-hAPT1 fragments encoding the hAPT1 (aa S2465-P2869) or
truncated hAPT1s (aa S2465-V2858) domain were cloned as a 1260-bp
BamHI/SalI or 1227-bp BamHI/SalI fragment into the 4960-bp BamHI/
SalI-digested pKF463 to obtain pDK101 or pDK101C. The I2771R mu-
tation was introduced into the hVPS13A-hAPT1 sequence by one-step
site-directed mutagenesis of pDK101. Then, the 1260-bp BamHI/SalI
fragment was cloned into the 4960-bp BamHI/SalI-digested pKF463 to
obtain pDK125.
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2.3. Western blot analysis
Yeast cells were grown at 28 °C on SC-ura to the logarithmic phase.
Protein extracts were prepared after disrupting cells with glass beads in
2× electrophoresis sample buffer (120 mM Tris-HCl (pH 6.8), 2% SDS,
20% glycerol, 0.04% bromophenol blue, 10% β-mercaptoethanol).
Samples were analysed by standard SDS-PAGE followed by Western
blot analysis using mouse monoclonal anti-GFP (Roche, Basel,
Switzerland), anti-NEDD4 (Millipore, Darmstadt, Germany), and sec-
ondary anti-mouse IgG horseradish peroxidase (HRP)-conjugated anti-
bodies (Dako, Glostrup, Denmark), and the signal was developed by
using enhanced chemiluminescence substrate (Millipore, Burlington,
USA) and detected with a CCD camera (AlphaInnotech, Genetic
Technologies, Miami, USA).
2.4. Purification of the Vps13 protein fragments
Truncated variants of chorein, Vps13 or Atg2 were expressed as N-
terminally GST-tagged recombinant proteins in the E. coli
SoluBL21(DE3) strain propagated at 28 °C in LB medium supplemented
with 0.2% glucose and 100 μg ml−1 ampicillin (Sigma-Aldrich, Saint
Louis, USA) for plasmid maintenance. Expression was induced with
0.1 mM IPTG for 1 h. Then, the cells were pelleted, resuspended in
equilibration buffer (125 mM Tris-HCl (pH 7.5), 150 mM NaCl) sup-
plemented with protease inhibitor cocktail (Complete Mini, EDTA free,
Roche) and lysed by sonication. The homogenate was centrifuged at
20000 ×g for 15 min at 4 °C. The supernatant was supplemented with
1 mM DL-dithiothreitol (DTT) and incubated with glutathione magnetic
beads (Thermo Scientific, Waltham, USA) for 2 h at 4 °C. After washing,
the bound proteins were eluted with 25 mM reduced glutathione in
elution buffer (125 mM Tris∙HCl (pH 8.0), 150 mM NaCl, 1 mM DTT),
and the integrity of the eluted proteins was analysed by Western blot-
ting.
2.5. Protein lipid overlay assay
The identification of lipids interacting with a given protein was
performed by an overlay assay. A membrane containing lipids (PIP
strips; Echelon Biosciences Inc., Salt Lake City, UT, USA) was blocked
with 3% fatty-acid-free BSA (Sigma-Aldrich) in TBS-T (TBS + 0.1%
Tween-20) for 1 h at room temperature and then incubated overnight at
4 °C in blocking buffer with 0.5–1 μg ml−1 of a particular protein or
GST alone as a negative control. Bound proteins were detected by
Western blot with anti-GST HRP-conjugated antibodies (BioLegend, San
Diego, USA).
2.6. Liposome binding assay
Liposomal assays were carried out using synthetic biotin-tagged
PolyPIPosomes containing 5% (w/w) individual PIPs, 65% (w/w)
phosphatidylcholine, 29% (w/w) phosphatidylethanolamine, and 1%
(w/w) biotin (Echelon Biosciences Inc.). The purified proteins GST-
hVps13A-(hAPT1), GST-hVps13A-I2749R-(hAPT1*), GST-Vps13-
(yAPT1v), GST-Atg2-(yAPT1a), and GST-hVps13A-(hAPT1s) or GST
alone as a negative control were incubated with 5 μl of the liposome
mixtures in 0.8 ml of reaction buffer (50 mM HEPES (pH 7.5), 150 mM
NaCl) supplemented with 2 mM EDTA, 1 mM Mg2+ or 1 mM Ca2+ for
30 min at room temperature. Next, 50 μl of Dynabeads MyOne
Streptavidin C1 (Invitrogen) was added to pull down the lipid-protein
mixtures and incubated for 1 h at 4 °C. Following 5 washes with 0.5 ml
of reaction buffer, the beads were mixed with 2× sample buffer
(120 mM Tris-HCl (pH 6.8), 2% SDS, 20% glycerol, 0.04% bromo-
phenol blue, 10% β-mercaptoethanol, 8 M urea) and processed for
Western blot analysis using anti-GST HRP-conjugated antibodies
(BioLegend). After the reaction, the supernatants were collected and
concentrated in Amicon centrifugal filters (Merck). The buffer in these
samples was exchanged with 8 M urea, and 4× sample buffer was
added. Densitometry analysis of the blots was performed with ImageJ
(https://imagej.nih.gov/ij/). Chart and statistical analyses were per-
formed in GraphPad Prism.
2.7. Ca2+-binding site prediction
To model the potential Ca2+ ion-binding sites of the APT1 domains,
the IonCom server (https://zhanglab.ccmb.med.umich.edu/IonCom/)
was used. The amino acid residue sequences used for the prediction
correspond to the fragments of the chorein (hAPT1), yeast Vps13
(yAPT1v) and Atg2 (yAPT1a) proteins used in the protein-lipid overlay
assay and in the liposome binding assay. The sequences were hAPT1, aa
2515–2919 (UniProt), yAPT1v, aa 2492–2844 and yAPT1a, aa
1079–1417 (Saccharomyces Genome Database).
2.8. Bioinformatics analysis
Protein homology detection and structure prediction was performed
through HHpred [36] and Phyre2 [37].
3. Results
3.1. The APT1 domain of chorein differs from that of Vps13
We previously found that the phenotypes caused by the VPS13 gene
deletion (vps13Δ) in yeast are not complemented by the cDNA of
hVPS13A [24]. Thus, to learn more about the function of chorein and its
domains, we focused on the APT1 domain. Earlier studies showed that
the APT1 domain, which we identified in the Vps13 and Atg2 proteins,
binds PI3P and that it is essential for proper functioning of the Vps13
protein [24,33]. A region with homology to the APT1 domain was also
found in chorein (aa 2600–2854) (probability: 97.03%, E value
0.00016, score 96.5) as determined by hidden Marcov model (HMM)
mapping using HHPred (Fig. S1) (http://toolkit.lmb.uni-muenchen.de/
hhpred). It is worth noting that all of the APT1 domains that we
characterized lacked N-terminus in contrast to the APT1 domain de-
scribed in the Pfam database. Because the hAPT1 domain that we
identified potentially overlaps with the DH-like domain (aa
2751–3027) determined by Kumar et al. (Fig. S2) [21], we additionally
performed bioinformatic analysis of chorein using Phyre2. Our analysis
indicated that the DH-like fold (fold id: c4uosA) starts at aa 2871 and
thus is located after the APT1 domain (Fig. S2).
Here, we documented whether the APT1 domain of Vps13 is in-
terchangeable with that of chorein. A domain swap experiment was
performed. We constructed yeast expression plasmid encoding chimeric
protein consisting of a Vps13 protein in which the yAPT1v domain (aa
2498–2844) was swapped with a domain originating from chorein,
hAPT1 (aa 2504–2869) (Fig. 1A). The fragments we exchanged had
additional N- and C-terminal unstructured flanks, as predicted by
Phyre2. In addition, the yAPT1v domain was also substituted for the
mutant hAPT1*, with an amino acid residue substitution found in ChAc
patient-derived chorein (I2771R). All chimeric proteins were GFP
tagged on the C-terminus because VPS13-GFP complemented all the
phenotypes of vps13Δ that we analysed, and VPS13-GFP was used as a
control. Next, the levels of the chimeric proteins in the yeast vps13Δ
strain transformed with the respective plasmids were tested. Western
blot analysis with anti-GFP antibodies demonstrated that all the chi-
meric proteins of appropriate molecular weights were produced
(Fig. 1B). This result allowed us to investigate the functionality of
chimeric proteins by analysing selected vps13Δ mutant phenotypes,
such as hypersensitivity to SDS [38] and canavanine [24]. The vps13Δ
strain was transformed with plasmids encoding all tested chimeric
proteins and with control plasmids encoding the wild-type Vps13 pro-
tein (Vps13-GFP), Vps13 lacking the yAPT1v domain (Vps13-APT1Δ-
GFP) or with an empty vector. Only a transformant bearing full-length
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yeast VPS13-GFP on a plasmid was able to grow on SDS- or canavanine-
containing plates, which revealed that under the tested conditions, the
yeast-human fusion VPS13 gene was not able to complement the lack of
VPS13 (Fig. 1C). Thus, the hAPT1 domain was not able to replace the
yAPT1v domain, suggesting that APT1 domains from yeast and human
Vps13 proteins differ significantly, even though their GFP-fusions were
similarly located in cells (Fig. S5), or the hAPT1 domain blocks the
action of the rest of the Vps13 protein. To identify the reason for the
observed difference between the yAPT1v and hAPT1 domains, we de-
termined whether they have different lipid partners.
We analysed the lipid binding of hAPT1 using a protein-lipid
overlay assay. The mutant hAPT1* domain was included into our
analysis to determine whether a pathogenic amino acid residue sub-
stitution affects lipid binding. The recombinant hAPT1 and hAPT1*
fused to GST (Fig. S3A) were tested for different glycerophospholipid
binding abilities. The analysis revealed that hAPT1 binds PI3P (Fig.
S3B) similar to the yAPT1v domain [24], but also binds phosphatidy-
linositol 5-phosphate (PI5P) and phosphatidylinositol 4-phosphate
(PI4P) (Fig. S3B). There was no difference in phospholipid binding
specificity between the hAPT1 and hAPT1* domains in this assay (Fig.
S3B). Thus, we found that the difference between the APT1 domains of
Vps13 and chorein is the ability to bind PI5P and PI4P; hAPT1 can bind
PI5P and PI4P, while yAPT1v cannot. This result confirmed our hy-
pothesis that the hAPT1 and yAPT1v domains may differ in lipid
binding specificity and prompted us to investigate this finding further.
We concentrated on binding of APT1 domains to PI5P and PI3P. The
characterization of their binding to PI4P remains for further studies.
3.2. hAPT1 binds PI3P in a bivalent-cation-dependent manner
To confirm the difference between the APT1 domains that we ob-
served in the protein-lipid overlay assay, the ability of GST-APT1 do-
main fusions (of both yeast and human origin; Fig. 2A) to bind PI3P- or
PI5P-enriched liposomes was tested. Moreover, we also examined how
metal ions affect binding. Lipid binding tests were performed in the
presence of EDTA chelating ions, in the presence of Mg2+ or Ca2+ ions.
These conditions were tested because the IonCom server (https://
zhanglab.ccmb.med.umich.edu/IonCom/) predicted that the hAPT1
domain potentially binds Ca2+ ions, while the domain from Vps13 does
not (Fig. S4). In all further experiments, biotin-tagged liposomes were
used, which were pulled down using streptavidin-covered beads. The
amount of recombinant protein bound to the liposomes was monitored
by Western blot analysis using an anti-GST antibody. Control experi-
ments were also conducted in which recombinant proteins were in-
cubated with liposomes without PIP enrichment (P0), liposomes with
phosphatidylinositol (PI) or without liposomes (-LIP). We previously
provided evidence that in a liposome binding assay the yAPT1v domain
binds PI3P in Mg2+-containing buffer [24]. Indeed, we recovered ap-
proximately 35–45% of the recombinant GST-yAPT1v, which was
added to the reaction, on liposomes containing PI3P, and the binding
Fig. 1. APT1 domains of Vps13 and chorein are not inter-
changeable. (A) Schematic representation of the Vps13 pro-
tein, its truncated variant, chorein, and chimeric Vps13 con-
sisting of a Vps13 protein in which the yAPT1v domain was
swapped with a hAPT1 domain originating from chorein. The
APT1 domains are indicated (yAPT1v in dark grey and hAPT1
in black). The numbering of amino acid residues in Vps13 and
chorein is given; numbers in brackets correspond to respective
amino acid residues in the chorein. The position of the iso-
leucine (I) residue substituted for arginine (R) in ChAc pa-
tients (I2771R) is indicated by asterisk. (B) The level of the
fusion proteins described in (A) in yeast vps13Δ. All proteins
were GFP tagged at the C-terminus. Cells were transformed
with plasmids bearing indicated alleles or empty vector [−]
and grown. Total protein extracts were prepared and analysed
by SDS-PAGE followed by Western blotting with anti-GFP and
anti-Nedd4 antibodies recognizing Rsp5 (loading control). (C)
Sensitivity of yeast strains to SDS and L-canavanine. Serial 4-
fold dilutions of wild-type and vps13Δ strains bearing the in-
dicated plasmids were spotted on YPD and YPD supplemented
with 0.0175% SDS or the synthetic medium SC-arg-ura sup-
plemented with 3 μg ml−1 L-canavanine (+Can) and in-
cubated at 28 °C for 2–7 days.
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occurred under all three tested conditions (+EDTA, +Mg2+ and
+Ca2+) with similar affinity (Fig. 2B). Binding to control liposomes
containing PI was also observed, but this binding was weak and not
statistically significant. No binding to liposomes devoid of any PIPs (P0)
was observed.
Interestingly, the binding of the GST-hAPT1 domain to PI3P was
found to be regulated. Approximately 20% of the recombinant GST-
hAPT1 protein was recovered on PI3P-containing liposomes in the ab-
sence of Ca2+ and Mg2+ ions, which was significantly different from
the binding of GST-hAPT1 to control liposomes (P0) but not to PI-
containing liposomes (Fig. 2C). In contrast to the EDTA condition, in
the presence of both tested cations, significant enhancement of binding
(approximately 70%–80%) of the recombinant GST-hAPT1 protein to
liposomes containing PI3P was observed (Fig. 2C). Thus, in the pre-
sence of Ca2+ or Mg2+ ions, the binding of hAPT1 to PI3P is preferred
over the binding to PI.
The amino acid residue substitution I2749R in the yAPT1v domain,
equivalent to the substitution I2771R found in a patient with ChAc,
causes a reduction in PI3P binding [24]. For this reason, we also tested
the effect of this substitution on the ability to bind PI3P in a natural
context, i.e., in the hAPT1 domain. The I2771R mutant (GST-hAPT1*;
Fig. 2A) was able to bind PI3P similarly under all studied conditions
(+EDTA, +Mg2+, +Ca2+), but this binding was much weaker than
that of wild-type hAPT1 (Fig. 2D). In fact, the binding of the mutant
hAPT1* domain to liposomes containing PI3P was at a similar level as
that of yAPT1v, which means that 40% of GST-hAPT1* was still re-
covered on liposomes containing PI3P. Similar to the Vps13 mutant
with the I2749R amino acid residue substitution [24], stronger binding
of GST-hAPT1* than GST-hAPT1 to PI-liposomes was observed (40%
versus 10%, respectively), in the presence of Ca2+ ions. In fact, binding
of hAPT1* to PI3P-containing liposomes was similar to binding to PI-
containing liposomes. Therefore, experiments have shown that sub-
stitution of I2771R in hAPT1 changes the affinity of this domain for
PI3P and PI, and regulation of PI3P binding by metal ions is lost.
3.3. The yAPT1a domain binds PI3P only in the presence of calcium ions
We next sought to determine how the APT1 domain from yeast Atg2
(yAPT1a) is regulated. The GST-yAPT1a fusion protein was purified
(Fig. 3A), and its binding characteristics with PI3P-containing lipo-
somes were investigated under all the conditions tested previously
(+EDTA, +Mg2+, +Ca2+). Surprisingly, GST-yAPT1a was able to
bind PI3P only in the presence of Ca2+ ions (Fig. 3B). Computational
analysis did not predict the ability of yAPT1a to bind Ca2+ ions (Fig.
S4), suggesting that the effect of Ca2+ on PI3P binding must differ.
Thus, even if the in silico study did not predict Ca2+ binding, it seems
that binding of Atg2 to membranes can be regulated by the effect of
Ca2+ ions on the yAPT1a domain. In general, these results showed that
the ability to bind PI3P is a characteristic feature of APT1 domains, but
there is a difference between domains in terms of the conditions needed
for this binding.
3.4. The C-terminally truncated hAPT1 domain loses the bivalent cation-
dependent ability to bind PI3P
In the hAPT1 domain, the amino acid residues important for Ca2+
binding are located at the C-terminus, as predicted by the IonCom
server (Fig. S4). To confirm whether these amino acids are actually
responsible for regulation of the cation-dependent binding of hAPT1 to
PI3P, we expressed a truncated hAPT1 lacking 11 aa at the C-terminus
(hAPT1s) (Fig. 4A). This truncated protein was used in tests for binding
to liposomes containing PI3P under all the previously tested conditions.
The binding of hAPT1s to PI3P was very weak in all conditions and the
metal ions Ca2+ or Mg2+ did not enhance this binding (Fig. 4B). This
result indicates that the deleted 11-amino-acid sequence from hAPT1 is
necessary for bivalent cation-mediated regulation of PI3P binding.
Taken together, these data indicate that the hAPT1 may be a new Ca2+-
and Mg2+-dependent PIP-binding domain.
3.5. The PI5P binding properties of the APT1 domain of chorein
As protein-lipid overlay assays revealed, the GST-hAPT1 domain
binds strongly to PI5P (Fig. S3B), while binding of GST-yAPT1v to PI5P
was not detected [24]. We were interested in whether this binding is
dependent on the presence of ions, as in the case of PI3P binding.
Hence, in the next step, we compared the APT1 domains of Vps13 and
chorein in the context of PI5P binding using the same conditions as
described above. Binding of yAPT1v to PI5P-containing liposomes was
observed only in the presence of calcium and was very weak;< 10% of
the GST-yAPT1v added to the reaction, (Fig. 5A), which was not sta-
tistically significant. In contrast, the hAPT1 domain was effectively
retained on liposomes containing PI5P, and this binding was not de-
pendent on the presence of cations. In this experiment, 30%–60% of the
recombinant hAPT1 protein was found on liposomes containing PI5P
(Fig. 5B). The I2771R mutation greatly reduced PI5P binding (to ap-
proximately 5% of the input level) in all conditions tested (Fig. 5C).
Thus, this analysis suggests that the I2771R mutation present in the
chorein of ChAc patient changes lipid binding and probably membrane
binding, which reduces the function of this protein at particular cellular
locations where PI3P and/or PI5P is present. This finding also indicates
that the reduction of chorein binding to specific regulatory lipids, such
as PIP, is pathogenic.
4. Discussion
Chorein, a human protein implicated in the neurodegenerative
disease chorea-acanthocytosis, has a poorly defined physiological
function. Chorein was found to be localized on the membranes of many
different organelles. This diversity in localization is achieved via the
interaction of its domains and motifs with lipids and proteins. These
interactions must be regulated, as indicated by the changes in locali-
zation of Vps13 depending on the growth conditions [18]. Our work
aimed to characterize the APT1 domain present in chorein, and in yeast
Vps13 and Atg2 proteins. Here, we have demonstrated that the hAPT1
Fig. 2. Binding of APT1 domains from Vps13 and chorein to PI- and PI3P-containing liposomes. (A) Schematic representation of the Vps13 and chorein with APT1
domains indicated (as in Fig. 1). Fragments fused to GST used in the liposome binding assay are shown. The position of the isoleucine (I) residue substituted for
arginine (R) in ChAc patients (I2771) is indicated by an asterisk. Western blot shows purified fragments used for the liposome binding assay. The purified proteins
GST-yAPT1v (B), GST-hAPT1 (C) and GST-hAPT1* (D) were incubated with the indicated biotin-tagged liposomes (P0, without any phosphoinositides; PI, liposomes
with 5% phosphatidylinositol; PI3P, liposomes with 5% phosphatidylinositol 3-phosphate) in three different conditions: with 2 mM EDTA (+EDTA); 1 mM MgCl2
(+Mg2+) or 1 mM CaCl2 (+Ca2+). Liposomes were pulled down using streptavidin-covered beads. All the fractions recovered, concentrated supernatants and
protein input were loaded onto the gel. The fusion proteins were detected using an anti-GST antibody. The upper panel of the blots shows proteins bound to liposomes
(LIP), and the lower panel presents an analysis of the fraction not bound to liposomes (SUP). A representative Western blot result of each analysis is presented. The
statistical analysis of the densitometry scans of the Western blots, performed using ImageJ software, is presented. The ratio between proteins bound to particular
liposomes and input was calculated. Statistical analysis: mean ± SD; t-test; p < .05*, p < .01**, p < .001***; ns, non-significant. Number of repetitions: N = 4–7
depending on experiment.
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domain binds to PI3P, lipid characteristic for endosomal/lysosomal
membranes. Our analysis also revealed that APT1 domains of various
proteins differ in their ability to bind various PIPs and that hAPT1 in-
teracts not only with PI3P but also with PI5P. Additionally, the ability
of different APT1 domains to interact with PIPs is differently regulated
by Mg2+ and/or Ca2+ ions. Both these ions enhanced the binding of the
hAPT1 domain to PI3P, and Ca2+ ions were necessary for the binding of
yAPT1a to PI3P. We showed that the I2771R substitution found in the
hAPT1 domain of the ChAc patient changes the interaction with PI3P in
a manner similar to the corresponding I2749R substitution in yAPT1v.
In addition, we have demonstrated that this substitution abolishes the
Ca2+ and Mg2+ stimulation of PI3P binding and shifts the affinity to-
wards PI. Therefore, our work suggests that chorein might be a protein
regulated by calcium signalling, and we propose that the loss of PI3P
binding regulation and reduced affinity of mutant hAPT1 for PI5P
binding are changes of great importance for cell physiology, they result
in ChAc pathogenesis.
Chorein was found to localize to ER-lipid droplet and ER-mi-
tochondria MCSs [21,22]. Nevertheless, chorein may be recruited to
many other cellular structures in response to different stimuli or con-
ditions. Although there is no evidence of the localization of chorein on
endosomal membranes, Vps13 and hVps13B were found in this com-
partment [19,39]. In endosomes, PI3P plays a role in the recruitment of
effector proteins responsible for the correct sorting of proteins into
vacuoles, Golgi apparatus and/or plasma membrane. PI3P is also ne-
cessary to regulate fusion of transport vesicles and in the process of
autophagy, where it regulates the growth of autophagosome [40]. The
Vps13 protein may therefore be one of the PI3P effectors, and its par-
ticipation in fusion of vesicles [26], protein sorting [41] and autophagy
[42] may depend on its recruitment to membranes containing PI3P.
Indeed, our previous work has shown that Vps13 not only binds to PI3P,
but PI3P also regulates the localization of Vps13 [20,24]. Thus, also
binding of chorein to endosomal/lysosomal membranes, enriched with
PI3P, might be regulated. Surprisingly, the hAPT1 domain binds not
only PI3P but also PI5P and PI4P. The role of PI5P in the cell is poorly
understood. It is estimated that PI5P accounts for approximately 0.5%
of the PIPs in a cell [43]. In mammalian cells, PI5P is localized to the
nucleus and non-nuclear membranes, including the plasma membrane,
endosomes ER or Golgi apparatus membranes [44,45]. PI5P plays a
crucial role in each of these compartments, where it affects remodelling
of the actin cytoskeleton, endocytosis [45–47], and nuclear signalling
[48–50]. It was found that the level of PI5P increases under some forms
of stress, such as hyperosmotic stress or oxidative stress [43]. Why is
the binding of hAPT1 to PI3P regulated by Mg2+ and/or Ca2+ but the
binding to PI5P is not regulated by these ions? This difference can have
two explanations: either hAPT1 has a high affinity for PI5P and ions are
not required to enhance this interaction or binding to PI5P is otherwise
regulated by an interaction with the chorein adapter protein that has
not yet been identified. The remaining questions to be answered are
regarding the role of PI5P in the regulation of chorein function and
localization in vivo. There is no evidence for the presence of PI5P in
yeast cells. Although Vps13 is important for survival under some forms
of stress, such as in the presence of SDS [38] or canavanine [24], it is
not clear how this feature can be linked to changes in interactions with
lipids. Hence, our results provide information only about the possible
role of PI5P as a regulator of chorein. PI5P could recruit chorein to
certain locations to facilitate the transfer of lipids to or from mem-
branes containing PI5P. There are also other domains that exhibit PI5P
Fig. 3. The influence of calcium on the binding of PI3P by the yAPT1a domain. (A) Schematic representation of the Atg2 protein with APT1 domain (yAPT1a in
white) and its fragment fused to GST. The Western blot analysis of purified fragment used for the liposome binding assay is shown. (B) Interaction of purified GST-
yAPT1a protein with PI3P-enriched liposomes was assayed and the statistical analysis was performed as described in Fig. 2. Number of repetitions: N = 3.
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binding, such as the VHS domain of the Tom1 protein, known as the
PI5P adaptor. It exhibits, in protein lipid overlay assay, a binding
profile to different PIPs similar to that of the hAPT1 domain [51].
Additionally, proteins containing the FYVE finger domain, associated
mainly with PI3P, may also weakly bind to PI5P [52,53]. Thus, dual
lipid binding specificity to PI3P and PI5P has been previously described
in the literature and is not a hAPT1-specific feature.
The regulation of the lipid binding activity of the APT1 domain by
ions is not surprising, as the interaction of lipids with effector proteins
has to be controlled. The C2 domain is an example of a lipid-binding
domain, which in some proteins is regulated by Ca2+. Interestingly, C2
domains are also described as having different selectivity for binding to
lipids at different Ca2+ ion concentrations [54]. The regulation of
hAPT1 binding to PI3P by Ca2+ may be physiologically significant.
Recruitment of yeast Vps13 to endosome and vacuole membranes is
most likely achieved by binding the Ypt35 adaptor in response to dif-
ferent conditions [27,55]. However, in yeast binding to Ypt35 may not
be sufficient to recruit Vps13 protein to membranes. Binding of the
Ypt35 adapter protein and yAPT1v domain to PI3P may act synergis-
tically to increase the recruitment efficiency of Vps13 protein to
membranes. Such cooperative membrane binding with several elements
is a common feature of many proteins [56]. In the case of hAPT1, the
ability of this protein to bind PI3P must be stimulated by the presence
of Ca2+ or Mg2+ ions. Although these ions are available in a cell the
hAPT1 cannot replace the yAPT1v domain suggesting that Ca2+ ions
local concentration may be insufficient. Another possibility is that the
chimeric protein, due to its hAPT1 properties, binds PI5P efficiently and
is therefore localized on an inappropriate membrane in the yeast cell.
However, in yeast cells the PI5P has not been found so far.
Our analysis of fluorescence microscopy images showed that the
location of both GFP-yAPT1v and GFP-hAPT1 proteins is similar to that
of yAPT1a [33] and coincides with the location of the chaperones of
Protein Quality Control (PQC) compartments, Hsp42 and Hsp104 (Fig.
S5). Both fusion proteins can be directed to this compartment because
are abnormal or Vps13 proteins have their specific role in PQC where
are recruited by the regulatory PIPs present in these structures. Recent
data show the deposition of misfolded proteins accompanied by Hsp104
near the mitochondria where they co-localize with the Vps13 and
Vps39 proteins in MCSs. These MCSs are involved in both physical and
functional formation of inclusions and their subsequent removal [57].
This association of aggregates with organelles suggests that specific li-
pids at these location may provide the necessary environment for dis-
aggregation [57]. In agreement with this idea are results showing that
PI3P regulates the yeast cell response to proteotoxic stress [33]. In
summary, the analysis indicates that the hAPT1 and yAPT1v domains,
similar to the yAPT1a domain of the Atg2 protein, may be responsible
for the recruitment of the respective proteins to PQC in response to
proteotoxic stress.
The fact that the yAPT1a domain of Atg2 binds PI3P-containing li-
posomes only in the presence of Ca2+ ions indicates that studies of the
APT1 domains should be performed in several different conditions,
particularly because Ca2+ ions binding could not be predicted in silico.
Our result can explain why Atg2 recruitment to liposomes with PI3P
increased only slightly compared to binding to liposomes without PI3P
in experiments described by Gómez-Sánchez et al. in which buffers
without Ca2+ and Mg2+ ions were used [58]. This result also suggests
that the regulation of the binding of yAPT1a to PI3P by Ca2+ must
differ from that of hAPT1. It is possible that the yAPT1a domain in-
teracts weakly with PI3P and that Ca2+ ions stabilize this binding via
one of the mechanisms similar to these described for C2 domain. In case
of the C2 domain, Ca2+ ions play at least three different roles: (1) Ca2+
binding changes the electrostatic potential of the domain; (2) Ca2+ ions
provide a bridge between the domain and membrane lipids and (3)
Ca2+ induces conformational changes in the domain/protein, which
Fig. 4. The influence of calcium on the binding of PI3P by the truncated hAPT1s domain. (A) Schematic representation of the chorein (as in Fig. 1) and its shortened
APT1 domain (hAPT1s) fused to GST. The Western blot analysis of purified fragment used for the liposome binding assay is shown. (B) Interaction of purified GST-
hAPT1s protein with PI3P-enriched liposomes was assayed and the statistical analysis was performed as described in Fig. 2. Number of repetitions: N = 5.
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Fig. 5. Binding of the yAPT1v and hAPT1 domains to PI5P-containing liposomes. The purified proteins GST-yAPT1v (A), GST-hAPT1 (B) and GST-hAPT1* (C) were
incubated with the indicated liposomes (-LIP no liposomes; P0, lacking any phosphoinositides; PI5P, liposomes with 5% PI5P) in three different conditions, with
2 mM EDTA (+EDTA), 1 mM MgCl2 (Mg2+) or 1 mM CaCl2 (Ca2+). The binding and statistical analyses were performed as in Fig. 2. t-test; p < .05*, p < .01**,
p < .001***; ns, non-significant. Number of repetitions: N = 4–7. Note that values on the Y axis differ among A, B and C.
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triggers interaction [59]. Additionally, the recruitment of Atg2 to
membranes within ER-preautophagosome MCS [60] cannot rely only
on interaction with lipids, but this process could be stabilized by ad-
ditional interaction with proteins, such as Atg9 via the APT1 domain
[58] and with Atg18 via other domains (Fig. 6A) [61]. The hAtg2A
protein interactions seem to be also regulated by Ca2+. In starvation or
pharmacologically induced autophagy, the protein of the autophagy
machinery WIPI-1, a homologue of yeast Atg18, which is a partner
protein of hAtg2A, accumulates in puncta corresponding to phagophore
membranes. The occurrence of this puncta is reduced in the presence of
BAPTA-AM (1,2-bis(O-aminophenoxy)ethane-N,N,N′,N′-tetra-acetic
acid tetra (acetoxymethyl) ester), a Ca2+ ion chelator [62]. Im-
portantly, addition of BAPTA-AM does not affect the production of PI3P
[62,63], indicating that the localization of the hAtg2A-WIPI-1 complex
on the edge of the nascent phagophore depends on the presence of Ca2+
ions. This finding can be explained by our result showing that the
binding of the yAPT1a domain to PI3P occurs only in the presence of
Ca2+ ions. Thus, subcellular localization of Atg2 proteins in the ER-
phagophore MCSs, a process that is essential for autophagy, may be
regulated by Ca2+ ions. This is an interesting result, indicating that one
of the early steps in the autophagy process is regulated by Ca2+ sig-
nalling.
To summarize we created the model shown in Fig. 6, which depicts
the regulation of the binding of different APT1 domains to membranes.
The binding of Vps13 to membranes containing PI3P, such as en-
dosomal membranes, could be achieved in two ways: by interaction of
yAPT1v with PI3P and by complementary binding to adaptor proteins
such as Ypt35 (Fig. 6B). In the case of chorein, the interacting adaptor
protein is not known and the recruitment to PI3P-rich compartments is
regulated by ions in the cytoplasm. Because the cellular Mg2+ con-
centration does not change significantly over time, the regulatory effect
of Mg2+ in cells is weak [64], and rather Ca2+ ions control the binding
of chorein to PI3P. There are three possible ways for Ca2+ to do this.
First, Ca2+ can interact with the hAPT1 domain and facilitate electro-
static binding to PI3P. Second, the hAPT1 domain can recognize and
bind to PI3P, but this binding is not stable, and Ca2+ ions can enhance
and stabilize this interaction (Fig. 6C). Third, the electrostatic correla-
tion between Ca2+ (and any bivalent ions) and the phosphomonoester
group of PI3P can be responsible for the enhanced deprotonation of
phosphate and, consequently, increasing negative charge leading to
strengthening of the interaction between the phospholipids and their
effector (Fig. 6D) [65].
Analysis of the impact of the I2771R substitution on the binding to
different PIs is important for understanding not only the regulation of
interactions between chorein and lipids but for understanding the me-
chanism of ChAc pathogenesis. The hAPT1 domain modelled by the
IonCom server suggests that the I2771R substitution of the chorein is
located in the vicinity of amino acid residues that interact with Ca2+.
Even though the positive charge provided by arginine could block the
binding of Ca2+ to the hAPT1 domain this hypothesis was not con-
firmed when hAPT1* was modelled by IonCom server. Another ex-
planation is that the I2771R substitution triggers structural changes
Fig. 6. Model of the regulation of APT1 domains. (A) The yAPT1a domain binds to membranes containing PI3P in a calcium-dependent-manner; (B) Binding of the
yAPT1v domain of Vps13 to membranes containing PI3P and concomitant interaction with the adaptor protein Ypt35; (C) The binding of the hAPT1 domain to PI3P
regulated by cations; (D) Influence of metal ions on the phosphate group of phosphoinositides; (E) Lack of regulation by cations due to I2771R substitution in hAPT1
and consequent reduction in the binding to PI3P. See text for details.
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within the hAPT1 domain, which reduces the interactions with PI3P
and PI5P without impacting Ca2+ binding but enhances the affinity for
PI (Fig. 6E). This enhanced binding of hAPT1* to PI can have a very
deleterious effect on cells and can be a reason for the pathogenicity of
the mutation. PI3P or PI5P are low-abundance lipids localized to spe-
cific membranes, while PI is ubiquitous [66]. Therefore, the ability to
interact with PI may result in the loss of specific chorein localization
and/or regulation, resulting in a phenotype similar to that caused by
the absence of chorein. Interactions with lipids have regulatory con-
sequences for many proteins, and there are many examples of diseases
that result from changes in phospholipid metabolism [67]. The muta-
tion I2771R in the APT1 domain of chorein is another example of such a
connection.
Here, the biochemical properties of APT1 domains were character-
ized, and differences between the domains were identified. The ob-
tained results are a basis for further structural studies that should an-
swer questions regarding the structural determinants underlying the
differences between APT1 domains, identify amino acid residues that
are important for Ca2+ ion binding and help to better understand pa-
thogenesis of all VPS13 and ATG2-related diseases.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbamem.2020.183349.
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